Option Care Health Inc

OPCH is exhibiting an early Stage 1 consolidation with a clear higher-highs & higher-lows structure and short-term EMAs shifting to support. The medium-term bias is bullish, backed by pattern asymmetry and tentative 9/21 EMA support within the base. Short-term timing is constructive with price tracking closely above these EMAs, justifying immediate buy-on-pullback entries. However, the longer-term downtrend remains intact, and a decisive break below the EMA cluster would invalidate this bullish stance.

• ↑Q1 2026 revenue $1.4B (+1% YoY); full-year guidance $5.675–$5.775B intact.
• ↑Acute therapies achieve high single-digit growth, backed by tech and process investments.
• ↓A $55M headwind in the CID portfolio dragged Q1 revenue growth by ~600bps.